Concurrent and Alluxio Team to Provide Scalable Data Analytics at Memory Speed
Partnership Expands Concurrent Market Opportunity into Storage for Analytics
ATLANTA, July 06, 2017 (GLOBE NEWSWIRE) -- Concurrent (NASDAQ:CCUR), a global leader in storage, protection, transformation and delivery of visual assets, and Alluxio, developers of the world's first system that unifies data at memory speed, today announced a joint solution that provides real-time data analytics and machine learning to help service providers analyze viewers' preferences and video consumption patterns.
The joint solution brings together Concurrent's Aquari(TM) Storage platform with Alluxio Enterprise Edition (AEE) to provide a faster and more scalable alternative for Hadoop users than the Hadoop Distributed File System (HDFS). This combination allows service providers to quickly extract and analyze vast amounts of data that were previously discarded as useless, helping to identify actionable insights and discover new revenue and customer retention opportunities.
"It is imperative that media service providers have the tools and resources they need to deliver content and take advantage of market opportunities immediately and without limitation," said Haoyuan Li, CEO at Alluxio. "By combining Alluxio's virtual distributed storage system with Concurrent Aquari scale-out storage, service providers will be able to deliver instantaneous information essential for targeted advertising and optimized content libraries, thereby growing revenue while keeping operational expenses under control."
Alluxio provides a unified view of enterprise data that spans disparate storage systems, locations and clouds, allowing any big data computational framework to access stored data at memory speed. Alluxio runs critical workloads for numerous Global 2000 companies that include Baidu, Barclay's Bank, CERN, ESRI, Huawei, Intel, and Juniper, among others.
Concurrent Aquari Storage is a modern, intelligent storage system that features simultaneous support for multiple file- or object-based workloads. Built on a true scale-out architecture, Aquari Storage seamlessly and independently scales throughput and capacity. This translates into increased flexibility and scalability to better manage growing visual asset libraries and the applications that process them.
"Concurrent has been providing tier-one service providers around the globe with high-availability storage solutions for decades," said Scott Ryan, Senior Vice President, Products at Concurrent. "By partnering with Alluxio, we are able to further enhance the availability and personalization of the services that our customers offer their end-users. This joint solution provides critical insight into how and when media is consumed and ensures that service providers can take advantage of real-time analysis at memory speed."
Alluxio is the world's first system that unifies data at memory speed. By allowing applications to access data stored in disparate storage systems at memory speed, Alluxio enables enterprises to manage data efficiently, accelerate business analytics, and ease the adoption of hybrid cloud. Venture-backed by Andreessen Horowitz, Alluxio, Inc. was founded by the creators of the Alluxio open source project. For more information, contact email@example.com or follow Alluxio on LinkedIn, Twitter or Facebook.
Concurrent (NASDAQ:CCUR) is a global software and solutions company that develops advanced applications focused on storing, protecting, transforming, and delivering high value media assets. We serve industries and customers that demand uncompromising performance, reliability and flexibility to gain a competitive edge, drive meaningful growth and confidently deliver best-in-class solutions that enrich the lives of millions of people around the world every day. Offices are located in North America, Europe and Asia. Visit www.concurrent.com for further information and follow us on Twitter: www.twitter.com/Concurrent_CCUR.
Certain statements made or incorporated by reference in this release may constitute "forward-looking statements" within the meaning of federal securities laws. Statements regarding future events and developments and a company's future performance, including, but not limited to, management's expectations, beliefs, plans, estimates, or projections relating to the future, are forward-looking statements within the meaning of these laws. All forward-looking statements are subject to certain risks and uncertainties that could cause actual events to differ materially from those projected.
Important risk factors include, but are not limited to, Concurrent's ability to reinvest the net proceeds from the sale of its Real-Time segment in a manner that Concurrent believes will generate an adequate return to its remaining business and the risk factors discussed in Concurrent's Form 10-K filed August 30, 2016 with the Securities and Exchange Commission ("SEC"), and in subsequent filings of periodic reports with the SEC. The risk factors discussed in the Form 10-K and subsequently filed periodic reports under the heading "Risk Factors" are specifically incorporated by reference in this press release. Forward-looking statements are based on current expectations and speak only as of the date of such statements. Concurrent undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of future events, new information, or otherwise.
All Concurrent product names and its logo are trademarks or registered trademarks of Concurrent while all other product names are trademarks or registered trademarks of their respective owners.
For more information, contact:
404-214-0722 X 103
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Concurrent Computer Corporation via Globenewswire
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från GlobeNewswire
Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00 | Pressmeddelande
STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o
Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07 | Pressmeddelande
PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr
Stillfront Group announces Head of M&A19.12.2018 12:07 | Pressmeddelande
PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess
Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41 | Pressmeddelande
Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört
Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41 | Pressmeddelande
Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum